Micrologix enters into exclusive license negotiation period to partner MBI-226.(Micrologix Biotech Inc. )(Specialty Pharma): An article from: BIOTECH Patent News Buy on Amazon
Facebook LinkedIn

Micrologix enters into exclusive license negotiation period to partner MBI-226.(Micrologix Biotech Inc. )(Specialty Pharma): An article from: BIOTECH Patent News

5.95 USD

Available for download now

Book Details
ISBN / ASIN B00082NEJ4
ISBN-13 978B00082NEJ6
Availability Available for download now
Marketplace United States 🇺🇸
Ratings & Reviews No reviews yet — be the first!

No reviews yet.

Description
This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on May 1, 2004. The length of the article is 618 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Micrologix enters into exclusive license negotiation period to partner MBI-226.(Micrologix Biotech Inc. )(Specialty Pharma)
Publication:BIOTECH Patent News (Newsletter)
Date: May 1, 2004
Publisher: Biotech Patent News
Volume: 18 Issue: 5

Distributed by Thomson Gale
Donate to EbookNetworking
No Prev
No Next